Neel Desai

Company: Biogen

Job title: Business Development & Licensing

Seminars:

BUILDING ON COBENFY TRIUMPH: WHAT DOES THIS MEAN FOR THE EVOLVING COMMERCIAL LANDSCAPE? 3:00 pm

Key hurdles in securing patents for psychotic medications and innovations Strategies for extending patent life (e.g., formulation changes, new indications) Cost factors unique to psychotic medication, including long trial durations and patient recruitment challenges Understanding the high-risk nature of psychiatric drug development and its impact on investor interest Key investment drivers and barriers to funding…Read more

day: Day Two

Roundtable Discussion: Benchmarking Opportunities, Risks & Challenges of Studying & Therapeutically Targeting Psychotic Symptoms in Dementia, Bipolar, PTSD, Depression, Autism, ADHD & More 4:00 pm

Practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas: Dementia-Associated Psychosis Bipolar & PTSD Severe Depression Autism & ADHD Moderators will be assigned to each roundtable to facilitate discussion and collate the findings. Following the roundtable discussions, they will present back to the entire delegation and…Read more

day: Day One